| 摘要 |
<p>The invention relates to 4-acylamino-1-azaadamantanes represented by general formula (I): <IMAGE> (I) wherein R represents an alkyl group, a substituted alkyl group, an aryl group or a substituted aryl group, useful in particular, for the treatment of cardiovascular diseases.</p> |
